This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Global Nuclear Medicine Industry

Digirad Bags FDA Clearance for Portable Imaging System II-42

Digirad Inks Asset Purchase Agreement with MD Office Solutions II-42

Positron Inks Agency Agreement with TIS II-43

Dilon Diagnostics Inks Agreement with Philips Healthcare II-43

11. FOCUS ON SELECT GLOBAL PLAYERS II-44Digirad Corporation ( USA) II-44GE Healthcare Plc (The United Kingdom) II-44Phillips Healthcare, Inc. ( USA) II-44Positron Corporation ( USA) II-44Siemens Medical Solutions USA, Inc. ( USA) II-45Toshiba Medical Systems Corporation ( Japan) II-45Toshiba America Medical Systems, Inc. ( USA) II-45


Table 8: World Recent Past, Current & Future Analysis for

Nuclear Medicine by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-46

Table 9: World Historic Review for Nuclear Medicine byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) II-47

Table 10: World 15-Year Perspective for Nuclear Medicine by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and

Rest of World Markets for Years 2004, 2011, & 2018 (includes

corresponding Graph/Chart) II-48

Nuclear Medicine Market by Product Segment II-49

Table 11: World Recent Past, Current & Future Analysis for

Gamma Cameras by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,355.30 +92.74 0.57%
S&P 500 1,852.84 +9.86 0.54%
NASDAQ 4,063.1330 +28.9720 0.72%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs